REFERENCES
- Aso Y, Anderson L, Soloway M, Bouffioux C, Chisholm G, Debruyne F, Kawai T, Kurth KH, Maru A, Straffon WGE. Prognostic Factors in Superficial Bladder Cancer. EORTC Genitourinary Group Monograph 3: Developments in Bladder Cancer. Alan R Liss. 1986: 257–269.
- Ausfeld R, Beer M, Muhlethaler J-P, Bartlome S, Widmer R and Tscholl R. Adjuvant Intravesical Chemotherapy of Superficial Bladder Cancer with monthly Doxorubicin or Intensive Mitomycin. A comparison of two consecutive series. Eur Urol 1987; 13: 10–14.
- Cutler SJ, Heney NM, Friedell GHL. Longitudinal study of patients with bladder cancer: Factors associated with disease recurrence and progression. In: Bonney WW, Prout GR Jr, eds AUA Monographs: Bladder Cancer, Baltimore: Williams and Wilkins 1982; 35–46.
- Denis L. Therapeutic use of Mitomycin C in bladder cancer. In: Bladder Cancer, Part B: Radiation. Local and Systemic Chemotherapy, and new treatment modalities, Alan R Liss Inc. 1984; 113–122.
- Eksborg S, Nilsson S-O, Edsmyr F. Intravesical instillation of adriamycin. A model for standardization of the chemotherapy. Eur Urol 1980; 6: 218–220.
- Green D, Robinson R, Gleshan R, Newling D, Delasio O, Smith P. Does Intravesical Chemotherapy prevent Invasive Bladder Cancer? J Urol 1984; 131.
- Gustafson H, Tribukait B, Esposti P-L. DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours. Scand J Urol Nephrol 1982; 16: 135–139.
- Gustafson H, Tribukait B, Esposti P-L. DNA profile and tumour progression in patients with superficial bladder tumours. Urol Res 1982; 10: 13–18.
- Herr H. Intravesical therapy. A critical revue, Urol Clin of North America 14: No 2, May 1987.
- Huland H, Otto U. Mitomycin instillation to prevent recurrence of superficial bladder carcinoma. Eur Urol 1983; 9: 84–86.
- Huland H, Otto U, Droese M, Kloppel G. Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: Influence on recurrence, progression and survival. J Urol 1984; 132: 27–29.
- Huland H, Klöppel G, Feddersen I, Otto U, Brachmann W, Hubmann H, Kaufmann J, Knipper W, Lantzius-Beninga F, Huland E. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: Final evaluation of a prospective multicenter study with 419 patients. J Urol 1990; 144: 68–71.
- Jacobi GH, Kurth KH. Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumour penetration. J Urol 1980; 124: 34.
- Kurth KH, Schroeder FH, Tunn U, Ay R. Members of the EORTC Genitourinary Tract Cancer Cooperative Group. Adjuvant chemotherapy of superficial bladder cancer: Preliminary results of a European Organization for Research on Treatment of Cancer randomized trial comparing doxorubicin, hydrochloride, ethylglucide, and transurethral resection alone. J Urol 1984; 132: 258–262.
- Lamm DL. BCG in carcinoma in situ and superficial bladder tumours. EORTC Genitourinary Group Monograph 5: Progress and controversies in oncological urology II: Alan Liss 1988: 497–507.
- Mostofi FK, Sobin LH, Tovloni H. WHO: International Histological Classification of Tumours. No. 10: Histological Tvping of Urinary Bladder Tumours (WHO. Geneva). 1973.
- Niijima T, Koiso K, Akaza H. Randomized clinical trial for chemoprophylaxis of recurrence in superficial bladder cancer. Proc. 13th Int. Congr. Chemother 1983; 240: 6–8.
- Prout G. Intravesical chemotherapy. In: Bladder Cancer. Part B: Radiation, local and systemic chemotherapy and New Treatment Modalities, pp 125–150. Alan R. Liss Inc. 1984.
- Schulmann CC, Robinson M, Denis L, et al. Prophylactic chemotherapy of superficial transitional cell carcinoma: An EORTC randomized trial comparing thiotepa, VM-26, and TUR alone. Eur Urol 1982; 8: 207–212.
- Soloway M. Selecting Initial Therapy for Bladder Cancer. Cancer 1987; 60: 502–513.
- Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J Urol 1987; 5: 108–122.
- UICC. TNM Classification of malignant tumours. P. Hermanek, L.H. Sobin Eds. Springer, 1987; 133–135.
- Zincke H, Utz D, Taylor W, Myers R, Leary F. Influence of thiotepa and doxorubicin instillation at the time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective, randomized, double-blind, controlled trial. J Urol 1983; 129: 505–509.